Global Mononucleosis Diagnostic Market Growth (Status and Outlook) 2025-2031

September 2025 | 118 pages | ID: GA9072AACC00EN
LP Information

Abstracts

According to this study, the global Mononucleosis Diagnostic market size will reach US$ million by 2031.

Mononucleosis (infection) is an acute, self-limited Infectious disease caused by EBV (a contagious virus, Epstein-Barr) . The clinical features were fever, Laryngitis, Hepatosplenomegaly, abnormal blood lymphocyte, abnormal lymphocyte, positive hetero-agglutination test and anti-EBV antibody in Vivo after infection. Adolescents and young adults (12 to 40 years old) are more likely to be affected.

This market is closely related to the pharmaceutical market.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Mononucleosis Diagnostic Industry Forecast” looks at past sales and reviews total world Mononucleosis Diagnostic sales in 2024, providing a comprehensive analysis by region and market sector of projected Mononucleosis Diagnostic sales for 2025 through 2031. With Mononucleosis Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mononucleosis Diagnostic industry.

This Insight Report provides a comprehensive analysis of the global Mononucleosis Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Mononucleosis Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mononucleosis Diagnostic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mononucleosis Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mononucleosis Diagnostic.

This report presents a comprehensive overview, market shares, and growth opportunities of Mononucleosis Diagnostic market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Monospot Test
• Complete Blood Count Test
• Epstein Barr Virus (EBV) Antibody Test

Segmentation by Application:

• Hospitals
• Laboratories
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott Laboratories
• ELITechGroup
• Beckman Coulter
• Bio-Rad Laboratories
• Cardinal Health
• Immunostics
• Meridian Bioscience
• Quidel Corporation
• Sekisui Diagnostics
• Thermo Fischer Scientific
• Siemens
• Biomerieux

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Mononucleosis Diagnostic Market Size (2020-2031)
  2.1.2 Mononucleosis Diagnostic Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Mononucleosis Diagnostic by Country/Region (2020, 2024 & 2031)
2.2 Mononucleosis Diagnostic Segment by Type
  2.2.1 Monospot Test
  2.2.2 Complete Blood Count Test
  2.2.3 Epstein Barr Virus (EBV) Antibody Test
2.3 Mononucleosis Diagnostic Market Size by Type
  2.3.1 Mononucleosis Diagnostic Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Mononucleosis Diagnostic Market Size Market Share by Type (2020-2025)
2.4 Mononucleosis Diagnostic Segment by Application
  2.4.1 Hospitals
  2.4.2 Laboratories
  2.4.3 Others
2.5 Mononucleosis Diagnostic Market Size by Application
  2.5.1 Mononucleosis Diagnostic Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Mononucleosis Diagnostic Market Size Market Share by Application (2020-2025)

3 MONONUCLEOSIS DIAGNOSTIC MARKET SIZE BY PLAYER

3.1 Mononucleosis Diagnostic Market Size Market Share by Player
  3.1.1 Global Mononucleosis Diagnostic Revenue by Player (2020-2025)
  3.1.2 Global Mononucleosis Diagnostic Revenue Market Share by Player (2020-2025)
3.2 Global Mononucleosis Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MONONUCLEOSIS DIAGNOSTIC BY REGION

4.1 Mononucleosis Diagnostic Market Size by Region (2020-2025)
4.2 Global Mononucleosis Diagnostic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mononucleosis Diagnostic Market Size Growth (2020-2025)
4.4 APAC Mononucleosis Diagnostic Market Size Growth (2020-2025)
4.5 Europe Mononucleosis Diagnostic Market Size Growth (2020-2025)
4.6 Middle East & Africa Mononucleosis Diagnostic Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Mononucleosis Diagnostic Market Size by Country (2020-2025)
5.2 Americas Mononucleosis Diagnostic Market Size by Type (2020-2025)
5.3 Americas Mononucleosis Diagnostic Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Mononucleosis Diagnostic Market Size by Region (2020-2025)
6.2 APAC Mononucleosis Diagnostic Market Size by Type (2020-2025)
6.3 APAC Mononucleosis Diagnostic Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Mononucleosis Diagnostic Market Size by Country (2020-2025)
7.2 Europe Mononucleosis Diagnostic Market Size by Type (2020-2025)
7.3 Europe Mononucleosis Diagnostic Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Mononucleosis Diagnostic by Region (2020-2025)
8.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Type (2020-2025)
8.3 Middle East & Africa Mononucleosis Diagnostic Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MONONUCLEOSIS DIAGNOSTIC MARKET FORECAST

10.1 Global Mononucleosis Diagnostic Forecast by Region (2026-2031)
  10.1.1 Global Mononucleosis Diagnostic Forecast by Region (2026-2031)
  10.1.2 Americas Mononucleosis Diagnostic Forecast
  10.1.3 APAC Mononucleosis Diagnostic Forecast
  10.1.4 Europe Mononucleosis Diagnostic Forecast
  10.1.5 Middle East & Africa Mononucleosis Diagnostic Forecast
10.2 Americas Mononucleosis Diagnostic Forecast by Country (2026-2031)
  10.2.1 United States Market Mononucleosis Diagnostic Forecast
  10.2.2 Canada Market Mononucleosis Diagnostic Forecast
  10.2.3 Mexico Market Mononucleosis Diagnostic Forecast
  10.2.4 Brazil Market Mononucleosis Diagnostic Forecast
10.3 APAC Mononucleosis Diagnostic Forecast by Region (2026-2031)
  10.3.1 China Mononucleosis Diagnostic Market Forecast
  10.3.2 Japan Market Mononucleosis Diagnostic Forecast
  10.3.3 Korea Market Mononucleosis Diagnostic Forecast
  10.3.4 Southeast Asia Market Mononucleosis Diagnostic Forecast
  10.3.5 India Market Mononucleosis Diagnostic Forecast
  10.3.6 Australia Market Mononucleosis Diagnostic Forecast
10.4 Europe Mononucleosis Diagnostic Forecast by Country (2026-2031)
  10.4.1 Germany Market Mononucleosis Diagnostic Forecast
  10.4.2 France Market Mononucleosis Diagnostic Forecast
  10.4.3 UK Market Mononucleosis Diagnostic Forecast
  10.4.4 Italy Market Mononucleosis Diagnostic Forecast
  10.4.5 Russia Market Mononucleosis Diagnostic Forecast
10.5 Middle East & Africa Mononucleosis Diagnostic Forecast by Region (2026-2031)
  10.5.1 Egypt Market Mononucleosis Diagnostic Forecast
  10.5.2 South Africa Market Mononucleosis Diagnostic Forecast
  10.5.3 Israel Market Mononucleosis Diagnostic Forecast
  10.5.4 Turkey Market Mononucleosis Diagnostic Forecast
10.6 Global Mononucleosis Diagnostic Forecast by Type (2026-2031)
10.7 Global Mononucleosis Diagnostic Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Mononucleosis Diagnostic Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Information
  11.1.2 Abbott Laboratories Mononucleosis Diagnostic Product Offered
  11.1.3 Abbott Laboratories Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abbott Laboratories Main Business Overview
  11.1.5 Abbott Laboratories Latest Developments
11.2 ELITechGroup
  11.2.1 ELITechGroup Company Information
  11.2.2 ELITechGroup Mononucleosis Diagnostic Product Offered
  11.2.3 ELITechGroup Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 ELITechGroup Main Business Overview
  11.2.5 ELITechGroup Latest Developments
11.3 Beckman Coulter
  11.3.1 Beckman Coulter Company Information
  11.3.2 Beckman Coulter Mononucleosis Diagnostic Product Offered
  11.3.3 Beckman Coulter Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Beckman Coulter Main Business Overview
  11.3.5 Beckman Coulter Latest Developments
11.4 Bio-Rad Laboratories
  11.4.1 Bio-Rad Laboratories Company Information
  11.4.2 Bio-Rad Laboratories Mononucleosis Diagnostic Product Offered
  11.4.3 Bio-Rad Laboratories Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Bio-Rad Laboratories Main Business Overview
  11.4.5 Bio-Rad Laboratories Latest Developments
11.5 Cardinal Health
  11.5.1 Cardinal Health Company Information
  11.5.2 Cardinal Health Mononucleosis Diagnostic Product Offered
  11.5.3 Cardinal Health Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Cardinal Health Main Business Overview
  11.5.5 Cardinal Health Latest Developments
11.6 Immunostics
  11.6.1 Immunostics Company Information
  11.6.2 Immunostics Mononucleosis Diagnostic Product Offered
  11.6.3 Immunostics Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Immunostics Main Business Overview
  11.6.5 Immunostics Latest Developments
11.7 Meridian Bioscience
  11.7.1 Meridian Bioscience Company Information
  11.7.2 Meridian Bioscience Mononucleosis Diagnostic Product Offered
  11.7.3 Meridian Bioscience Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Meridian Bioscience Main Business Overview
  11.7.5 Meridian Bioscience Latest Developments
11.8 Quidel Corporation
  11.8.1 Quidel Corporation Company Information
  11.8.2 Quidel Corporation Mononucleosis Diagnostic Product Offered
  11.8.3 Quidel Corporation Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Quidel Corporation Main Business Overview
  11.8.5 Quidel Corporation Latest Developments
11.9 Sekisui Diagnostics
  11.9.1 Sekisui Diagnostics Company Information
  11.9.2 Sekisui Diagnostics Mononucleosis Diagnostic Product Offered
  11.9.3 Sekisui Diagnostics Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Sekisui Diagnostics Main Business Overview
  11.9.5 Sekisui Diagnostics Latest Developments
11.10 Thermo Fischer Scientific
  11.10.1 Thermo Fischer Scientific Company Information
  11.10.2 Thermo Fischer Scientific Mononucleosis Diagnostic Product Offered
  11.10.3 Thermo Fischer Scientific Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Thermo Fischer Scientific Main Business Overview
  11.10.5 Thermo Fischer Scientific Latest Developments
11.11 Siemens
  11.11.1 Siemens Company Information
  11.11.2 Siemens Mononucleosis Diagnostic Product Offered
  11.11.3 Siemens Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Siemens Main Business Overview
  11.11.5 Siemens Latest Developments
11.12 Biomerieux
  11.12.1 Biomerieux Company Information
  11.12.2 Biomerieux Mononucleosis Diagnostic Product Offered
  11.12.3 Biomerieux Mononucleosis Diagnostic Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Biomerieux Main Business Overview
  11.12.5 Biomerieux Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Mononucleosis Diagnostic Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Mononucleosis Diagnostic Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monospot Test
Table 4. Major Players of Complete Blood Count Test
Table 5. Major Players of Epstein Barr Virus (EBV) Antibody Test
Table 6. Mononucleosis Diagnostic Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Mononucleosis Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Mononucleosis Diagnostic Market Size Market Share by Type (2020-2025)
Table 9. Mononucleosis Diagnostic Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Mononucleosis Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Mononucleosis Diagnostic Market Size Market Share by Application (2020-2025)
Table 12. Global Mononucleosis Diagnostic Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Mononucleosis Diagnostic Revenue Market Share by Player (2020-2025)
Table 14. Mononucleosis Diagnostic Key Players Head office and Products Offered
Table 15. Mononucleosis Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Mononucleosis Diagnostic Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Mononucleosis Diagnostic Market Size Market Share by Region (2020-2025)
Table 20. Global Mononucleosis Diagnostic Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Mononucleosis Diagnostic Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Mononucleosis Diagnostic Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Mononucleosis Diagnostic Market Size Market Share by Country (2020-2025)
Table 24. Americas Mononucleosis Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Mononucleosis Diagnostic Market Size Market Share by Type (2020-2025)
Table 26. Americas Mononucleosis Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Mononucleosis Diagnostic Market Size Market Share by Application (2020-2025)
Table 28. APAC Mononucleosis Diagnostic Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Mononucleosis Diagnostic Market Size Market Share by Region (2020-2025)
Table 30. APAC Mononucleosis Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Mononucleosis Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Mononucleosis Diagnostic Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Mononucleosis Diagnostic Market Size Market Share by Country (2020-2025)
Table 34. Europe Mononucleosis Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Mononucleosis Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Mononucleosis Diagnostic Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Mononucleosis Diagnostic Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Mononucleosis Diagnostic Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Mononucleosis Diagnostic
Table 40. Key Market Challenges & Risks of Mononucleosis Diagnostic
Table 41. Key Industry Trends of Mononucleosis Diagnostic
Table 42. Global Mononucleosis Diagnostic Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Mononucleosis Diagnostic Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Mononucleosis Diagnostic Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Mononucleosis Diagnostic Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Abbott Laboratories Details, Company Type, Mononucleosis Diagnostic Area Served and Its Competitors
Table 47. Abbott Laboratories Mononucleosis Diagnostic Product Offered
Table 48. Abbott Laboratories Mononucleosis Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Abbott Laboratories Main Business
Table 50. Abbott Laboratories Latest Developments
Table 51. ELITechGroup Details, Company Type, Mononucleosis Diagnostic Area Served and Its Competitors
Table 52. ELITechGroup Mononucleosis Diagnostic Product Offered
Table 53. ELITechGroup Mononucleosis Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. ELITechGroup Main Business
Table 55. ELITechGroup Latest Developments
Table 56. Beckman Coulter Details, Company Type, Mononucleosis Diagnostic Area Served and Its Competitors
Table 57. Beckman Coulter Mononucleosis Diagnostic Product Offered
Table 58. Beckman Coulter Mononucleosis Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Beckman Coulter Main Business
Table 60. Beckman Coulter Latest Developments
Table 61. Bio-Rad Laboratories Details, Company Type, Mononucleosis Diagnostic Area Served and Its Competitors
Table 62. Bio-Rad Laboratories Mononucleosis Diagnostic Product Offered
Table 63. Bio-Rad Laboratories Mononucleosis Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Bio-Rad Laboratories Main Business
Table 65. Bio-Rad Laboratories Latest Developments
Table 66. Cardinal Health Details, Company Type, Mononucleosis Diagnostic Area Served and Its Competitors
Table 67. Cardinal Health Mononucleosis Diagnostic Product Offered
Table 68. Cardinal Health Mononucleosis Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Cardinal Health Main Business
Table 70. Cardinal Health Latest Developments
Table 71. Immunostics Details, Company Type, Mononucleosis Diagnostic Area Served and Its Competitors
Table 72. Immunostics Mononucleosis Diagnostic Product Offered
Table 73. Immunostics Mononucleosis Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Immunostics Main Business
Table 75. Immunostics Latest Developments
Table 76. Meridian Bioscience Details, Company Type, Mononucleosis Diagnostic Area Served and Its Competitors
Table 77. Meridian Bioscience Mononucleosis Diagnostic Product Offered
Table 78. Meridian Bioscience Mononucleosis Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Meridian Bioscience Main Business
Table 80. Meridian Bioscience Latest Developments
Table 81. Quidel Corporation Details, Company Type, Mononucleosis Diagnostic Area Served and Its Competitors
Table 82. Quidel Corporation Mononucleosis Diagnostic Product Offered
Table 83. Quidel Corporation Mononucleosis Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Quidel Corporation Main Business
Table 85. Quidel Corporation Latest Developments
Table 86. Sekisui Diagnostics Details, Company Type, Mononucleosis Diagnostic Area Served and Its Competitors
Table 87. Sekisui Diagnostics Mononucleosis Diagnostic Product Offered
Table 88. Sekisui Diagnostics Mononucleosis Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Sekisui Diagnostics Main Business
Table 90. Sekisui Diagnostics Latest Developments
Table 91. Thermo Fischer Scientific Details, Company Type, Mononucleosis Diagnostic Area Served and Its Competitors
Table 92. Thermo Fischer Scientific Mononucleosis Diagnostic Product Offered
Table 93. Thermo Fischer Scientific Mononucleosis Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Thermo Fischer Scientific Main Business
Table 95. Thermo Fischer Scientific Latest Developments
Table 96. Siemens Details, Company Type, Mononucleosis Diagnostic Area Served and Its Competitors
Table 97. Siemens Mononucleosis Diagnostic Product Offered
Table 98. Siemens Mononucleosis Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Siemens Main Business
Table 100. Siemens Latest Developments
Table 101. Biomerieux Details, Company Type, Mononucleosis Diagnostic Area Served and Its Competitors
Table 102. Biomerieux Mononucleosis Diagnostic Product Offered
Table 103. Biomerieux Mononucleosis Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Biomerieux Main Business
Table 105. Biomerieux Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Mononucleosis Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Mononucleosis Diagnostic Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Mononucleosis Diagnostic Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Mononucleosis Diagnostic Sales Market Share by Country/Region (2024)
Figure 8. Mononucleosis Diagnostic Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Mononucleosis Diagnostic Market Size Market Share by Type in 2024
Figure 10. Mononucleosis Diagnostic in Hospitals
Figure 11. Global Mononucleosis Diagnostic Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Mononucleosis Diagnostic in Laboratories
Figure 13. Global Mononucleosis Diagnostic Market: Laboratories (2020-2025) & ($ millions)
Figure 14. Mononucleosis Diagnostic in Others
Figure 15. Global Mononucleosis Diagnostic Market: Others (2020-2025) & ($ millions)
Figure 16. Global Mononucleosis Diagnostic Market Size Market Share by Application in 2024
Figure 17. Global Mononucleosis Diagnostic Revenue Market Share by Player in 2024
Figure 18. Global Mononucleosis Diagnostic Market Size Market Share by Region (2020-2025)
Figure 19. Americas Mononucleosis Diagnostic Market Size 2020-2025 ($ millions)
Figure 20. APAC Mononucleosis Diagnostic Market Size 2020-2025 ($ millions)
Figure 21. Europe Mononucleosis Diagnostic Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Mononucleosis Diagnostic Market Size 2020-2025 ($ millions)
Figure 23. Americas Mononucleosis Diagnostic Value Market Share by Country in 2024
Figure 24. United States Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Mononucleosis Diagnostic Market Size Market Share by Region in 2024
Figure 29. APAC Mononucleosis Diagnostic Market Size Market Share by Type (2020-2025)
Figure 30. APAC Mononucleosis Diagnostic Market Size Market Share by Application (2020-2025)
Figure 31. China Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 35. India Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Mononucleosis Diagnostic Market Size Market Share by Country in 2024
Figure 38. Europe Mononucleosis Diagnostic Market Size Market Share by Type (2020-2025)
Figure 39. Europe Mononucleosis Diagnostic Market Size Market Share by Application (2020-2025)
Figure 40. Germany Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 41. France Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Mononucleosis Diagnostic Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Mononucleosis Diagnostic Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Mononucleosis Diagnostic Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Mononucleosis Diagnostic Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 54. APAC Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 55. Europe Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 57. United States Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 58. Canada Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 59. Mexico Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 60. Brazil Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 61. China Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 62. Japan Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 63. Korea Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 65. India Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 66. Australia Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 67. Germany Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 68. France Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 69. UK Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 70. Italy Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 71. Russia Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 72. Egypt Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 73. South Africa Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 74. Israel Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 75. Turkey Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)
Figure 76. Global Mononucleosis Diagnostic Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Mononucleosis Diagnostic Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Mononucleosis Diagnostic Market Size 2026-2031 ($ millions)